Return to Clinical Trials Search Results

MK2870-012 Phase III study of MK-2870 Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR

Phase

III

Recruitment Status

Current Studies

View on
ClinicalTrials.gov